Buzzy is FDA cleared to “Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.”

Studies average 56 - 88% pain reduction. In our IV trial, on average Buzzy decreased pain by 50%. The greater the fear of needles (needle phobia) the better Buzzy works. Buzzy does not eliminate pain for everyone. In studies, about 3% of people experience no relief from Buzzy.

Buzzy is contraindicated for those with a sensitivity to cold, including Raynaud's, sickle cell disease, or CRPS.

Check out our Clinical Research.